Kouchakji Elias 4
4 · FIBROGEN INC · Filed Mar 18, 2020
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Transactions
- Tax Payment
Common Stock
2020-03-06$39.71/sh−6,525$259,108→ 94,691 total - Award
Stock Option (Right to Buy)
2020-03-17+62,500→ 62,500 totalExercise: $26.41Exp: 2030-03-17→ Common Stock (62,500 underlying) - Award
Common Stock
2020-03-17+37,500→ 132,191 total
Footnotes (3)
- [F1]Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
- [F2]Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- [F3]Twenty-five percent of the shares subject to the option vests March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years.